Tm Bioscience Sells Mayo Foundation on P450-2D6 Test

Sep 17, 2003

NEW YORK, Sept. 17 (GenomeWeb News) - Tm Bioscience of Toronto today announced that the Mayo Foundation has signed a two-year agreement to purchase the Tm Tag-It brand P450-2D6 drug metabolism test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

Quidel Q2 Revenues Down 2 Percent
Genomic Vision 1H 2017 Revenues Up 15 Percent
Coimbra Genomics Supporting Portugese Clinical Exome Sequencing Initiative
UPDATE: CRISPR Stakeholders Seek Reversal of Patent Interference Proceeding Decision
Thermo Fisher Scientific Q2 Revenues Up 10 Percent; Firm Increases 2017 Guidance Again
Adaptive Biotechnologies, NCI Collaborate on Immunosequencing Biomarker Discovery

The Scan

Cloud Ready

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

The Science and Policy Connection

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

The New Yeast

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

This Week in Cell

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.

Main menu